Mibelle launches metabolism boosting ingredient for sports nutrition and healthy aging

By Stephen Daniells

- Last updated on GMT

Santa herba (Eriodictyon californicum) is also known as mountain balm or yerba santa.  Image © Andrei Stanescu / Getty Images
Santa herba (Eriodictyon californicum) is also known as mountain balm or yerba santa. Image © Andrei Stanescu / Getty Images
Derived from santa herba leaves, Mibelle’s new metabolism boosting SantEnergy Nu ingredient is positioned for a number of different applications, including caffeine replacement, healthy aging, sports nutrition, and weight management.

SantEnergy Nu is prepared from the leaves of the santa herba (Eriodictyon californicum​), a member of the borage family and native to the Pacific Coast areas of Oregon, California and Mexico, explained Mibelle in a press release. The herb is reportedly rich in essential oils and polyphenols, including homoeriodictyol, eriodictyol and sterubin. It was used in traditional medicine to treat upper respiratory infections.

The ingredient is reported to be effective the formation of advanced glycation end products (AGEs), non-enzymatic modifications of proteins or lipids after exposure to sugars.

While AGEs form naturally as we age, they can also form in the presence of excess blood sugar as a result of a carbohydrate-rich diet. Their accumulation in adipose and liver tissues can interfere with many protein functions, resulting in an unbalanced metabolism and the onset of metabolic diseases.

SantEnergy Nu is said to activate the human adenosine receptor, a protein expressed in adipose tissues which regulates lipolysis and inflammation. Caffeine also interacts with the same receptor to produce its stimulating effects.

Mibelle has sponsored a placebo-controlled, double blind, randomized clinical trial with 50 obese volunteers (average age 47.5) to substantiate the ingredient’s efficacy. Twelve weeks of supplementation with SantEnergy Nu at a daily dose of 400 mg led to body weight and body fat significantly reduced in these women, said the company.

Details for the clinical trial can be found at ClinicalTrials.gov​.

Dr Torsten Grothe, Head of Food & Health for Mibelle Group, told NutraIngredients-USA that the clinical data are currently unpublished and that the company is in the process of preparing the manuscript, which would be submitted to a peer-review journal later this month.

Related news

Show more

Related products

show more

Brand Owners – Are You Getting the Supplement You Want?

Brand Owners – Are You Getting the Supplement You Want?

Content provided by Gemini Pharmaceuticals, Inc | 01-Nov-2024 | White Paper

Often the balance of “best value” and “best price” walks Brand Owners into a maze, and no industry seems to exemplify that like dietary supplements! However,...

Explore the scientific foundations of Nextida™ GC

Explore the scientific foundations of Nextida™ GC

Content provided by Rousselot | 01-Nov-2024 | White Paper

The first commercialised ingredient in the Nextida platform, a range of specific collagen peptide compositions with targeted health benefits, Nextida™...

Your Product Innovation Begins Here: Booth 4055

Your Product Innovation Begins Here: Booth 4055

Content provided by Effepharm Ltd | 22-Oct-2024 | Product Brochure

EffePharm will showcase innovative anti-aging solutions, featuring UthPeak™, world’s first self-GRAS approved NMNH, which boosts NAD+ levels by 10X. UthPeak™...

Related suppliers

Follow us

Products

View more

Webinars